Medical and Health Science Journal

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Volume 12
Issue 3
Online publication date 2012-07-27
Title Effect of HGV-infection on clinical course of hepatitis C and the possible role of endogenous interferon
Author Aizhan Dzhumagalieva, Idelbay Shuratov, Maria Omarova, Lyazat Orakbay, Daniyar Aspetov
Abstract Light form of disease flow was observed in 69.3% (9/13) among the patients with acute hepatitis C, and in 77.8% (7/9) among the patients with non verified hepatitis. Detectability of RNA-HGV consists of 77.8% (7/9) and 42.8% (3/7) correspondingly among the patients’ groups with light form of disease. All HGV RNA positive patients had 2 times lower content of total bilirubin and ALT in the blood comparing to RNA-HGV negative patients. HGV showed an active (4.7 EA) ability to induce the interferon formation. The C G hepatitis patients had interferon titer equal to 3.7 EA, which apparently provides relief of hepatitis C clinical picture.
Citation
References
Aspetov, D., Zhumatov, B., Zhansarina, A., 2003. “Interferogennye properties of bacteria Listeria monocytogenes,” Journal of KazNMU [Vestnik KazNMU], in Russian, No.4, pp.118-24

Chams, V., Fournier-Wirth, C., Chabanel, A. et al., 2003. “Is GB virus C alias “hepatitis” G virus involved in human pathology,” Transfus. Clin. Biol. Vol.10, pp.292-306

Enomoto, M., Shuhei, N., Fukuda, K. et al., 1998. “Characteristics of patients with hepatitis С virus with and without GB virus С / hepatitis G virus co-infection and efficacy of interferon alfa,” Hepatology, Vol.27, pp.1388-393

Karayiannis, P., Hadziannis, S., Kim, J. et al., 1997. “HGV-infection: Clinical characteristics and response to interferon,” J. Viral Hepatitis, Vol.4(1), pp.37-44

Kiyosawa, K., Tanaka, E., 1999. “GB – virus C/Hepatitis G virus,” J Intervirology, Vol.42, pp.185-95

Lau, D., Miller, K., Detmer, J. et al., 1999. “Hepatitis G virus human immunodeficiency virus co infection response to interferon – alpha therapy,” J. Ynteet. Dis., Vol.180, pp.1334-337

Muerhoff, A., Tillmann, H., Manns, M. et al., 2003. “GBV-C genotype determination in GBV-C/HIV co infected individuals,” J. Med. Virol., Vol.70, pp.141-49

Muerhoff, A., Simons, J., Leary, T., 1996. “Sequence heterogeneity within the 51-terminal region of the hepatitis GBV-C genome and evidence for genotypes,” J. Hepatol., Vol.25(3), pp.379-84

Novikov, V., Mohonov, V., 2001. “GB virus С (GBV-C/HGV),” World of Viral Hepatitis [Mir virusnyh gepatitov], in Russian, No.2, pp.2-4

Novohatskiy, A., Cherkashkina, N., Ershov, F., 1978. “The accelerated method of display of interferon in experimental infection,” Problems of Virology [Voprosy virusologii], in Russian, No.3, pp.303-306

Tanaka, E., Alter, H., Nakatsuji, Y. et al. 1996. “Effect of HGV infection on chronic hepatitis C,”Annals of Internal Medicine, Vol.125(9), pp.740-43

Keywords C-hepatitis, clinical course, co-infection, HCV HGV, induction of interferon HGV
Pages 40-43
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Share
Search in articles
Statistics
Journal Published articles
MHSJ 940
Journal Hits
MHSJ 2214063
Journal Downloads
MHSJ 16962
Total users online -